ANGLE Plc is a holding company, which engages in the provision of its subsidiaries engages in providing products in cancer diagnostics and foetal health. The company is headquartered in Guildford, Surrey and currently employs 119 full-time employees. The company went IPO on 2004-03-17. Its CTC harvesting technology, known as the Parsortix PC1 System, enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is an in vitro diagnostic device intended to enrich CTCs from peripheral blood collected in K2EDTA tubes from patients diagnosed with metastatic breast cancer. The company offers the Portrait+ CTC Staining Kit, which is a ready-to-use laboratory kit for the identification, characterization and enumeration of epithelial and mesenchymal circulating tumor cells, including those undergoing epithelial-to-mesenchymal transition. Its Parsortix PR1 System is a semi-automated platform for epitope-independent CTC isolation, used in research and clinical trials for multiple cancer types.
